Objective: Research supports the efficacy and safety of restrictive transfusion protocols to reduce avoidable RBC transfusions, but evidence of their effectiveness in practice is limited. This study assessed whether admission to an ICU with an restrictive transfusion protocol reduces the likelihood of transfusion for adult patients. Design: Observational study using data from the multicenter, cohort Critical Illness Outcomes Study. Patient-level analyses were conducted with RBC transfusion on day of enrollment as the outcome and admission to an ICU with a restrictive transfusion protocol as the exposure of interest. Covariates included demographics, hospital course (e.g., lowest hematocrit, blood loss), severity of illness (e.g., Sequential Organ Failure Assessment score), interventions (e.g., sedation/analgesia), and ICU characteristics (e.g., size). Multivariable logistic regression modeling assessed the independent effects of restrictive transfusion protocols on transfusions. Setting: Fifty-nine U.S. ICUs. Patients: A total of 6,027 adult ICU patients. Interventions: None. Measurements and Main Results: Of the 59 study ICUs, 24 had an restrictive transfusion protocol; 2,510 patients (41.6%) were in an ICU with an restrictive transfusion protocol. The frequency of RBC transfusion among patients with severe (hematocrit, < 21%), moderate (hematocrit, 21-30%), and mild (hematocrit, > 30%) anemia in restrictive transfusion protocol ICUs was 67%, 19%, and 4%, respectively, compared with 60%, 14%, and 2% for those in ICUs without an restrictive transfusion protocol. Only 27% of transfusions were associated with a hematocrit less than 21%. Adjusting for confounding factors, restrictive transfusion protocols independently reduced the odds of transfusion in moderate anemia with an odds ratio of 0.59 (95% CI, 0.36-0.96) while demonstrating no effect in mild (p = 0.93) or severe (p = 0.52) anemia. Conclusions: In this sample of ICU patients, transfusions often occurred outside evidence-based guidelines, but admission to an ICU with an restrictive transfusion protocol did reduce the risk of transfusion in moderately anemic patients controlling for patient
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Evaluation of RBC Transfusion Practice in Adult ICUs and the Effect of Restrictive Transfusion Protocols on Routine Care
A nemia is a common, life-threatening condition among critically ill patients, and almost 40% of ICU patients receive a RBC transfusion during their stay (1) (2) (3) . However, high rates of transfusions are associated with increased cost, infection rate, multiple organ failure, and mortality (1, 4, 5) . Unnecessary transfusions should be avoided to reduce the risk of harm and excess costs.
Clinical studies have demonstrated the efficacy and safety of restrictive transfusion protocols (RTPs) targeting thresholds of hemoglobin less than 7 g/dL or hematocrit less than 21% for most ICU patients (6) (7) (8) (9) (10) . Spurred by this evidence, medical professional organizations have issued evidence-based practice guidelines that reflect these findings, including the Society of Critical Care Medicine in 2009, the Society of Thoracic Surgeons in 2011, and the American Association of Blood Banks in 2012 (11) (12) (13) . Nevertheless, a significant proportion of RBC transfusions in the ICU continue to occur above recommended thresholds, with adoption varying between hospitals (14, 15) .
Evidence suggests that organizational interventions such as clinical protocols are important drivers of optimal ICU care (16) (17) (18) (19) . Significant opportunities remain to better characterize the adoption of these strategies and describe their effectiveness on improving of ICU care (20, 21) . RBC transfusion protocols exemplify this with a survey in 2000 reporting that less than 20% of ICUs had transfusion protocols, with no effect on practice detected (2) . Findings from single-center studies of such interventions may be limited in their ability to generalize results to other sites (22) (23) (24) .
Given the limited understanding of transfusion protocols in routine clinical practice, we assessed whether the presence of a RTP is independently associated with a lower risk of transfusion for patients in the range of moderate anemia where new evidence discourages transfusion as a default.
MATERIALS AnD METhODS

Study Design and Population
We conducted a planned secondary analysis of data accrued by the U.S. Critical Illness and Injury Trials Group-Critical Illness Outcomes Study (CIOS), a multicenter, prospective, observational study. CIOS collected data on structural ICU characteristics and the health status and management of individual patients in 2010 and 2011 to assess the effect of ICU process factors on mortality (25) (26) (27) . Our analysis used data on ICU and patient factors to evaluate the effectiveness of RTPs in usual care.
All adult patients in one of 59 study ICUs at 8 am on survey days were eligible for enrollment, excluding those already enrolled. Patient data were extracted from the medical record regarding baseline characteristics from admission and hospital course during the prior 24 hours. We excluded patients without transfusion status or hematocrit recorded.
Study Variables
The primary outcome was whether a patient had an RBC transfusion during the 24 hours preceding enrollment. The primary exposure was the presence of any RTP in each ICU, defined using the Medline MeSH subject heading of "a precise and detailed plan for a regimen of therapy," which includes guiding rules initiated by a provider order or included as part of standing orders during admission (25) . RTPs are expected to influence transfusion practice most in the range between customary restrictive (hematocrit, 21%) and liberal (hematocrit, 30%) transfusion thresholds, so RTPs were assessed in three categories of mild (hematocrit, ≥ 30%), moderate (21% ≤ hematocrit < 30%), and severe (hematocrit, < 21%) anemia.
Patient characteristics from demographics, comorbidities, admission diagnoses, operative status, and hospital course were selected on the basis of biological plausibility and previous research. Patient demographics included age, sex, and race (white vs other). Comorbid illnesses included any history of chronic diseases or specifically chronic kidney disease or cancer. Admission diagnoses were captured as independent, dichotomous variables for any diagnoses in the CNS, circulatory system, respiratory system, or trauma. Patient operative status was classified as postoperative from elective surgery and emergent surgery or as nonoperative.
Hospital course variables from the prior 24 hours included clinical indications of anemia, shock, and factors previously reported to influence transfusion decisions. Severity of illness was described using the Acute Physiology and Chronic Health Evaluation (APACHE) II score (28) and the Sequential Organ Failure Assessment score (29) . Shock was defined for clinical interpretation by a lowest mean arterial blood pressure less than 65 mm Hg or vasopressor administration. A diagnosis of sepsis or acute kidney injury and use of renal replacement therapy or continuous sedation and analgesia were also included as covariates. Degree of anemia was defined by the lowest hematocrit during the study period as a surrogate for the pretransfusion hemoglobin (30) . Blood loss was categorized as gastrointestinal bleeding and bleeding from any other source (e.g., procedure, operation).
Hospital and ICU structural characteristics were expected to be significant determinants of transfusion practice. Hospital characteristics of total beds and use of computerized physician order entry were included. The ICU type (medical, surgical, or mixed), bed count, annual admissions, staffing model (open, semiopen, or closed), and total number of protocols used were also considered as potential confounding exposures. considered normal according to study protocol. Covariates were modeled on the basis of published literature, and when such information was not available, we examined a scatter plot of the covariate and outcome using locally weighted regression to determine appropriate modeling (31) . Unadjusted, bivariate regression analyses were conducted with the odds of transfusion on the patient level for both patient and unit characteristics.
Hospital-level variation in transfusion practice was expected for factors not captured in this study (e.g., regional differences, local initiatives). A random-effects term for hospital was used to account for clustering while optimizing generalizability of an RTP to an ICU. After checking for collinearity, we created a mixed-effect logistic regression model to evaluate the likelihood of transfusion among those in a unit with an RTP versus one without, independent of patient and organizational factors. We used backward elimination for parsimony considering a 10% change in the RTP variable as criteria for eliminating a covariate as a confounder from the final model. Surgical and mixed medical-surgical ICUs were forced into the model, demonstrated the same effect, and were collapsed. In this modeling, hematocrit was a continuous covariate using 21% and 30% as knots in a linear spline function, and the resulting three categories were used for the effect of an RTP. A second model with the same covariates, using five-indicator variables for categories of hematocrit and RTP effects within each, was created to assess the appropriateness of modeling the hematocrit range of 21-30% as continuous.
All participating CIOS sites received institutional review board approval with a waiver of informed consent (32) . SAS 9.3 software (SAS Institute, Cary, NC) was used for all statistical analyses. Twosided p values less than 0.05 were considered significant.
RESuLTS
Participants
Data were collected from 6,179 patients at 36 hospitals in 59 ICUs, of which 23 were medical, 22 surgical, and 14 mixed ICUs (Fig. 1) . We excluded 25 patients without a documented transfusion status and 127 without a hematocrit or hemoglobin recorded. Of the remaining 6,027 patients, 42% were enrolled at ICUs with an RTP, whereas the remaining 58% were not exposed to an RTP.
In this sample, participants in ICUs with RTPs were older (mean age, 61.9 vs 57.9 yr; p < 0.0001) and more often white (76% vs 62%; p < 0.0001), with similar APACHE II scores (mean, 16.5 vs 16.7; p = 0.40) compared with those in non-RTP ICUs ( Table 1) . No significant difference existed in the average severity of anemia or frequency of bleeding between the groups. Participants exposed to RTPs were more often postoperative, hypotensive, with acute kidney injury, and on continuous infusion of sedatives or analgesics; those in non-RTP units more often had respiratory diagnoses. Patients in units with RTPs were more often in surgical, smaller, and closed ICUs, and those units had more protocols.
Transfusion Outcomes
A total of 771 patients (12.8%) were transfused in the 24-hour study period ( Table 2) . Of those transfused, the average lowest hematocrit was 23.6% (sd, 6.4%). Only 27% were more anemic than the restrictive transfusion threshold (hematocrit, < 21%), whereas 63% had a hematocrit of 21-30% (Supplemental Fig.  1 , Supplemental Digital Content 1, http://links.lww.com/CCM/ C153; legend: Distribution of anemia among patients that received an RBC transfusion [n = 771]). Nonbleeding patients were transfused with a similar distribution of anemia, 24% having a hematocrit less than 21%. In unadjusted analyses, patients in RTP ICUs received RBCs more often with average transfusion frequencies of 67%, 19%, and 4% among severe (hematocrit, < 21%), moderate (hematocrit, 21-30%), and mild (> 30%) anemia, respectively, compared with 60%, 14%, and 2% for those in ICUs without an RTP (Fig. 2) . Similarly, the presence of an RTP was associated with a higher average nadir hematocrit among those transfused (24.1% vs 23.0%; p = 0.002).
After adjusting for confounding covariates, however, the presence of an RTP was associated with a reduction in the probability of transfusion across the spectrum of anemia (Fig.  3A) . Furthermore, with hematocrit modeled as a continuous variable, the presence of an RTP was independently associated with a 31% reduction in the odds of transfusion in the intended range (21% ≤ hematocrit < 30%), where restrictive guidelines recommend against transfusion (OR, 0.59; 95% CI, 0.36-0.96). Outside this range, where restrictive and liberal strategies agree, there was no association in more anemic or less anemic patients (Fig. 3B) . Sensitivity analyses excluding bleeding patients did not alter these findings. In the adjusted model, blood loss was highly associated with an increased odds of transfusion (gastrointestinal bleed AOR, 15.0; 95% CI, 10.5-21.3). Differences in hematocrit affected odds of transfusion significantly in the range of 21-30% (for 1% change; AOR, 0.71; 95% CI, 0.64-0.78). Differences above 30% had a smaller effect, and those less than 21% had no effect. Shock and acute kidney injury were also significant risk factors in the adjusted model, although diagnoses of CNS or respiratory system decreased the risk (Table 2) .
For ICU covariates in the final model, higher ICU bed count was associated with a reduced likelihood of transfusion, whereas annual volume had the opposite association. The number of protocols overall in each ICU was independently associated with transfusion as well (AOR, 1.07; 95% CI, 1.03-1.12).
DISCuSSIOn
This investigation used data from a large, multicenter, prospective cohort study to assess the effects of RTPs on the likelihood of transfusion controlling for other patient and ICU factors. Our analysis identified two important findings. First, RBC transfusions remain common in ICUs and continue to occur outside of evidence-based guidelines. Second, the presence of an RTP reduces the odds of transfusion by more than 40% for ICU patients with anemia in the range between the restrictive and liberal guidelines (hematocrit, 21-30%), sparing many avoidable transfusions.
Our study extends existing literature describing the prevalence of anemia and RBC transfusions in critical illness. We demonstrate that RBC transfusions remain common for ICU patients with a daily incidence of nearly 13%, a lower average nadir hematocrit in this study of 23.6% (comparable with hemoglobin of 7.9 g/dL), and 73% of transfused patients had a nadir hemoglobin greater than 7 g/dL (Supplemental Fig. 1 , Supplemental Digital Content 1, http://links.lww.com/CCM/ C153). In two large studies describing transfusion practices in European and U.S. ICUs, Vincent et al (1) and Corwin et al (2) reported mean pretransfusion hemoglobins of 8.4 and 8.6 g/dL, respectively. Although direct comparisons are difficult, RBC utilization may be moving closer to evidence-based guidelines.
This study also contributes to research on the effect of ICU characteristics and clinical protocols on transfusions (24) . Practice variation attributable to clinician factors can be seen in differences among institutions adopting new restrictive transfusion evidence (15) , and in variations among specialties and individuals (33, 34) . For interventions intended to affect clinicians' practice, however, prior studies implementing transfusion guidelines or protocols are frequently single center "before-after" studies (23, 35, 36) . Many studies also included other initiatives, like education (37), targeted provider feedback (22, 38, 39) , communication with blood bank staff (40) , or a combination of these (41) (42) (43) , reflecting local barriers and solutions.
In unadjusted analyses, ICUs with RTPs provided more transfusions and transfused patients with less severe anemia than ICUs without RTPs, but patients in these ICUs with protocols also had a higher proportion of risk factors for transfusion both in their physiology (e.g., shock) and care setting (e.g., surgical, smaller ICUs). Although clinical indications for each transfusion were not recorded, in the final model, anemia, bleeding, shock, and acute kidney injury are each risk factors for transfusion consistent with clinical practice. Higher volume ICUs have been associated with adoption of restrictive transfusion practices, and we demonstrate a similar effect (15) . However, controlling for volume, larger ICU size is also associated with a decreased likelihood of transfusion, possibly as an adjustment for patient turnover. The total number of protocols in each ICU was an independent risk factor as well, suggesting that this structural attribute may influence transfusions even when these protocols are not strictly related to blood product use. In the range between restrictive and liberal thresholds for transfusion, RBC use has been associated with equivalent or worse outcomes in large clinical trials, and of all patients in this sample, 49% were in this range of moderate anemia (Hébert et al [6] ). This study quantifies the effect of an RTP for decreasing the daily likelihood of transfusions in this group, where reducing avoidable transfusions represents an improvement toward better, more evidence-based care. Our findings suggest that of the 237 patients transfused with moderate anemia at ICUs without a protocol, an RTP could have reduced that number by 88. Furthermore, we find no effect of RTPs outside this range, supporting the conclusion that clinical protocols effectively change provider behavior toward more restrictive practice.
Finally, we also demonstrate that most transfusions still occur above the restrictive threshold, even in the setting of an RTP, suggesting additional opportunities to reduce avoidable risk in current transfusion practice.
Replicable mechanisms, like protocols, to bring new evidence into clinical practice are important to high-quality care for ICU patients. In particular, when evidence shows that withholding an intervention reduces the risk of future harm, full adoption faces a unique challenge: the decision not to intervene goes against Final adjusted model for RBC transfusion by hematocrit comparing exposure to a restrictive transfusion protocol (RTP) versus not exposed, adjusting for covariates with A, hematocrit as categoric variable and the effect of an RTP as independent in each category and b, hematocrit as a continuous variable with spline knots at hematocrits of 21% and 30% and RTP effects assessed in each range relative to spline knots. Predicted adjusted outcomes were calculated for a patient with mean values for all other covariates. Gray band indicates 95% CI for adjusted odds ratio (OR) of transfusion for an RTP. On the study day, 228 patients (63%) with an hematocrit less than 21% were transfused, 239 (32%) with hematocrit 21-23.9%, 152 (13.9%) with hematocrit 24-26.9%, 82 (7.4%) with hematocrit 27-29.9%, and 70 (2.6%) with hematocrit greater than 30%.
physiologic reasoning of clinicians. CIOS provides patient and ICU data across many sites allowing for generalizable conclusions about how deliberately "precise and detailed plan(s)" for transfusion decisions affect practice, and in this analysis, RTPs show effectiveness in reducing avoidable transfusions, translating evidence from clinical trials into routine care.
Despite the abundance of information captured, several limitations to this observational study exist. First, these data were collected in 2010 and 2011, and since that time several studies have demonstrated the safety of restrictive transfusion strategies in additional patient populations, which may further drive adoption of restrictive transfusion practice (8, (44) (45) (46) . Still, this study demonstrates a delay in translating evidence into clinical practice 11 years after the landmark Transfusion Requirements in Critical Care trial was published, and it investigates the mechanism by which RTPs affect routine clinical practice (6) .
Second, unmeasured ICU structure or provider practice patterns may confound the observed association between a transfusion protocol and transfusion decisions. This study used a robust dataset with rich organizational data that reduce, but do not eliminate this risk. Future studies should continue to consider these factors and better define those relevant to replicable strategies.
Third, "protocol", as defined in our study, used provides one measure for existing interventions, but captures neither features within each RTP nor whether protocols were actually used for individual patients (47) . Additionally, other interventions to address appropriate RBC use, such as education and feedback, are frequently implemented in combination with protocols, which were not captured for this analysis. Subsequent studies should examine the specific attributes of protocols and their relationship to improving evidence-based practice.
Finally, this study was not designed to assess the effect of an RTP on patient outcomes like mortality, but rather on RBC transfusion practice in a single day. The dataset did not capture the number of units given per transfusion or the number of transfusions per admission. Assessing variables in a 24-hour period allows for analysis of clinical decisions, but reveals less about total exposure to blood products. Additional studies should consider assessing these outcomes as potential consequences of protocolized practice.
COnCLuSIOnS
In this sample of critically ill patients, anemia and therapeutic RBC transfusions were very common. These transfusions often occurred above evidence-based thresholds; however, RTPs were associated with an independent reduction in the risk of transfusion for patients with moderate anemia when other patient and ICU factors were taken into consideration. Transfusion protocols may have a significant role in reducing avoidable transfusions, and methods to drive and assess behavior change in transfusion practice deserve continued examination to improve evidence-based care.
